FDA Approvals in Oncology: April-June 2026
During the second quarter of 2026, oncology approvals issued by the U.S. Food and Drug Administration expanded the treatment...
During the second quarter of 2026, oncology approvals issued by the U.S. Food and Drug Administration expanded the treatment...
Elizabeth M. Jaffee and Antoni Ribas will look to feature the next wave of immuno-oncology advances as Cancer Immunology Research's...
The AACR, The Mark Foundation, Lustgarten Foundation, Break Through Cancer, and Tina’s Wish will explore early detection approaches for...
What does a naked mole rat, a nuclear exporter that “moonlights” as a chromatin regulator, and the combined power...
Cancer Today's winter 2025-2026 issue covers delaying stem cell transplants in multiple myeloma, new treatments for brain metastases, and...
What are fusion proteins? Learn more about how improperly combined genes and their protein products can lead to cancer.
At an AACR special conference on early-onset cancers, researchers discussed microplastics, the global rise of these cancers, and more.
An AACR Special Conference on early-onset cancers explored possible explanations for the alarming increase in cancer among younger adults.
Recently updated federal guidelines for cervical cancer screening and the HPV vaccine could make these prevention strategies more convenient.
Keith Flaherty, William Hait, Nina Bhardwaj, Dana Pe’er, and Marcia Cruz-Correa forecast what advances to expect in cancer research...
In the last quarter of 2025, the FDA announced 20 approvals in oncology, including treatments for lung cancer, multiple...